| Dr Brian C Birch, MD | |
|
2921 S Meridian Rd, Meridian, ID 83642-7961 | |
| (208) 297-7847 | |
| (208) 203-0097 |
| Full Name | Dr Brian C Birch |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 2921 S Meridian Rd, Meridian, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194042713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | M-12019 (Idaho) | Primary |
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
According to a new report by iData Research, the leading authority in medical device and pharmaceutical market research, the U.S. peripheral vascular device market is worth $2.8 billion with expected growth to over $5.3 billion by 2016. Increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD) are the main drivers of this market, particularly in the stent-graft and peripheral vascular stent segments. These markets are both expected to exceed $1 billion by 2016.
There are currently only two FDA-approved medications for the treatment of posttraumatic stress disorder (PTSD) in the United States. Both of these medications are serotonin uptake inhibitors. Despite the availability of these medications, many people diagnosed with PTSD remain symptomatic, highlighting the need for new medications for PTSD treatment.
Today, Citizens for Pennsylvania's Future (PennFuture), joined by leaders from the Group Against Smog and Pollution (GASP) and Clean Water Action, along with Dr. Evelyn O. Talbott of the University of Pittsburgh Graduate School of Public Health Department of Epidemiology and Allegheny County Council President Richard Fitzgerald, announced a major new campaign to reduce the fine soot pollution responsible for Pittsburgh's number one ranking for dirtiest air for two years running.
Immune system cells called macrophages spring into action to surround and destroy threats such as viruses or cancer cells. But sometimes the would-be protective response leads to persistent inflammation, which, in turn, can cause disease.Scientists don't know exactly how macrophages cross the line from being good cops to bad cops, but researchers at the University of Florida recently unearthed several clues about the mechanisms involved. Through the lens of two inflammation-related diseases, HIV and rheumatoid arthritis, they identified changes in specific proteins linked to the action of macrophages, white blood cells that are key to the body's natural defenses.
A group of scientists from Hamburg may have taken a big step towards more effective cancer drug development, Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], heard today (Wednesday 23 September). Dr Ilona Schonn, Director of Cell Culture Research at Indivumed GmbH, told the conference that they had developed a preclinical drug test platform that would enable researchers to analyse tumour tissue for individual patient drug responses on the molecular level.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian C Birch, MD 1775 W State St # 229, Boise, ID 83702-3924 Ph: (208) 297-7847 | Dr Brian C Birch, MD 2921 S Meridian Rd, Meridian, ID 83642-7961 Ph: (208) 297-7847 |
News Archive
According to a new report by iData Research, the leading authority in medical device and pharmaceutical market research, the U.S. peripheral vascular device market is worth $2.8 billion with expected growth to over $5.3 billion by 2016. Increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD) are the main drivers of this market, particularly in the stent-graft and peripheral vascular stent segments. These markets are both expected to exceed $1 billion by 2016.
There are currently only two FDA-approved medications for the treatment of posttraumatic stress disorder (PTSD) in the United States. Both of these medications are serotonin uptake inhibitors. Despite the availability of these medications, many people diagnosed with PTSD remain symptomatic, highlighting the need for new medications for PTSD treatment.
Today, Citizens for Pennsylvania's Future (PennFuture), joined by leaders from the Group Against Smog and Pollution (GASP) and Clean Water Action, along with Dr. Evelyn O. Talbott of the University of Pittsburgh Graduate School of Public Health Department of Epidemiology and Allegheny County Council President Richard Fitzgerald, announced a major new campaign to reduce the fine soot pollution responsible for Pittsburgh's number one ranking for dirtiest air for two years running.
Immune system cells called macrophages spring into action to surround and destroy threats such as viruses or cancer cells. But sometimes the would-be protective response leads to persistent inflammation, which, in turn, can cause disease.Scientists don't know exactly how macrophages cross the line from being good cops to bad cops, but researchers at the University of Florida recently unearthed several clues about the mechanisms involved. Through the lens of two inflammation-related diseases, HIV and rheumatoid arthritis, they identified changes in specific proteins linked to the action of macrophages, white blood cells that are key to the body's natural defenses.
A group of scientists from Hamburg may have taken a big step towards more effective cancer drug development, Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], heard today (Wednesday 23 September). Dr Ilona Schonn, Director of Cell Culture Research at Indivumed GmbH, told the conference that they had developed a preclinical drug test platform that would enable researchers to analyse tumour tissue for individual patient drug responses on the molecular level.
› Verified 9 days ago
Kristina Miles, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 3277 E Louise Dr Ste 200, Meridian, ID 83642 Phone: 208-463-3000 | |
Mrs. Anne E. Riffle, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3653 N. Locust Grove Road, Meridian, ID 83646 Phone: 208-338-5437 Fax: 208-939-9811 | |
Robert F Adams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 520 S Eagle Rd, Meridian, ID 83642 Phone: 208-336-9188 | |
Joshua Edwin Albright, Pediatrics Medicare: Medicare Enrolled Practice Location: 1620 S Celebration Ave, Meridian, ID 83642 Phone: 208-884-1030 | |
Lisa M. Barker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1620 S Celebration Ave, Meridian, ID 83642 Phone: 208-884-1030 | |
Susan C Kim, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3280 E Lanark Dr, Meridian, ID 83642 Phone: 208-377-4400 Fax: 208-377-4416 |